Shared Health Services Blog

"Physician-use peptides. Third-party tested. A new revenue stream without a heavy lift." If an email like that has reached your wound care program — and this month, three reached ours — this is how to read it. An FDA advisory committee just recommended four peptides for compounding, against its own scientists' advice. We break down what that vote does and doesn't mean, why compoundable isn't approved, and the questions to ask before a patient does.

A grateful patient thanked "the doctor who saved my foot" — but it was the nurse practitioner. That small confusion sits on a real question: how should the people who deliver care be classified? In wound care and HBOT, the physician/clinician/supplier distinctions aren't a vocabulary debate — they're the architecture behind HBOT supervision, incident-to billing, and MAC/RAC audit defense. Here's why getting the role right is a documentation problem your program can actually s

Mr. Gary Lane walked into a 25-bed Critical Access Hospital in rural Texas with a healable diabetic foot wound. Six weeks later, it was chronic. Nobody made a clinical mistake. The 2024 international Delphi consensus has a name for what happened: when adequate blood supply is present but the healthcare system lacks required resources, the wound has been clinically converted from healable to maintenance status. This is the wound care infrastructure problem nobody names.

Why do two wound care patients with identical clinical profiles heal differently? New peer-reviewed research from MUSC, George Washington University, and UCLA identifies a measurable biological mechanism behind a pattern wound care teams have been observing for as long as wound centers have existed — and the implications for how chronic wound and HBOT programs screen, document, and protect their clinical value are significant.

Recent H-1B visa policy shifts have moved physician recruitment from a predictable variable expense to a high-barrier fixed cost, fundamentally altering the financial calculus for rural wound care and HBOT programs. When physician availability becomes uncertain, operational infrastructure stops being discretionary—it becomes the foundation ensuring continuity of care. Discover how standardized protocols, trained staff, and telemedicine capability protect programs through staf

Hospitals and physician practices launching a wound care and hyperbaric oxygen therapy (HBOT) program must meet NFPA 99 standards from day one. This post breaks down critical Chapter 14 requirements—including safety the hyperbaric coordinator role, chamber classifications, fire protection systems, electrical guidelines, and survey readiness—and explains how SHS supports partners in building compliant, high-performing HBOT programs that reduce risk and deliver lasting value.

Choosing the right wound care partner can shape your program’s success for years to come. At Shared Health Services, we provide hospitals and physician practices with market-specific data, financial forecasting, and compliance expertise—empowering your team to launch and sustain high-performing wound care and HBOT services.